CHINA REGENERATIVE MEDICINE INTERNATIONAL LIMITED
THE STOCK EXCHANGE OF HONG KONG LIMITED
(A wholly-owned subsidiary of Hong Kong Exchanges and Clearing Limited)
FF003G
APPENDIX 5 FORMS RELATING TO LISTING FORM F THE GROWTH ENTERPRISE MARKET (GEM) COMPANY INFORMATION SHEETCase Number:
Hong Kong Exchanges and Clearing Limited and The Stock Exchange of Hong Kong Limited take no responsibility for the contents of this information sheet, make no representation as to its accuracy or completeness and expressly disclaim any liability whatsoever for any loss howsoever arising from or in reliance upon the whole or any part of the contents of this information sheet.
Company name: China Bio-Med Regeneration Technology Limited
Stock code (ordinary shares): 8158
This information sheet contains certain particulars concerning the above company (the "Company") which is listed on the Growth Enterprise Market ("GEM") of the Stock Exchange of Hong Kong Limited (the "Exchange"). These particulars are provided for the purpose of giving information to the public with regard to the Company in compliance with the Rules Governing the Listing of Securities on the Growth Enterprise Market of The Stock Exchange of Hong Kong Limited (the "GEM Listing Rules"). They will be displayed at the GEM website on the Internet. This information sheet does not purport to be a complete summary of information relevant to the Company and/or its securities.
The information in this sheet was updated as of 31 December 2014
Place of incorporation: Cayman Islands
Date of initial listing on GEM: 18 July 2001
Name of Sponsor(s): None
Names of directors:
(please distinguish the status of the directors
- Executive, Non-Executive or Independent
Non-Executive)
Executive Directors
Mr. Dai Yumin
Ms. Wang Yurong
Non-executive Directors
Mr. Wong Sai Hung (Chairman)
Professor Deng Shaoping
Mr. Cao Fushun
Mr. Yang Zhengguo
Mr. Ma Long
Mr. Wang Jianjun
Independent Non-executive Directors
Mr. Lui Tin Nang
Mr. Chan Wing Hang
Mr. Pang Chung Fai Benny
Mr. Chan Bing Woon, SBS, JP
FF003G
THE STOCK EXCHANGE OF HONG KONG LIMITED
(A wholly-owned subsidiary of Hong Kong Exchanges and Clearing Limited)
Name(s) of substantial shareholder(s):
(as such term is defined in rule 1.01 of the GEM Listing Rules) and their respective interests in the ordinary shares and other securities of the Company
All Favour Holdings Limited (Note 1): 14.15% Forerunner Technology Limited (Note 1): 14.15% Dai Yumin (Note 1): 14.15%
China Sheng Rong Investment Holding Limited (Note 2): 10.07% Wang Yurong (Note 2): 10.07%
Guan Baker Guo Liang (Note 2): 10.07%
Note 1:
All Favour Holdings Limited ("All Favour") is beneficially owned as to (i) 40% by Forerunner Technology Limited ("Forerunner Technology") and 20% by Honour Top Holdings Limited which in turn are ultimately wholly-owned by Mr. Dai Yumin, an executive Director; and (ii) 40% by Mr. Hu Yonggang, respectively. By virtue of the Securities and Futures Ordinance (Chapter 571 of the Laws of Hong Kong) (the "SFO"), Mr. Dai, Mr. Hu and Forerunner Technology are deemed to be interested in
1,685,320,319 shares of the Company held by All Favour.
Note 2:
China Sheng Rong Investment Holding Limited ("Sheng Rong") is beneficially owned as to (i) 51% by Mr. Guan Baker Guo Liang; and (ii) 49% by Ms. Wang Yurong, an executive Director. Mr. Guan and Ms. Wang are spouses. By virtue of the SFO, Ms. Wang and Mr. Guan are deemed to be interested in 1,200,000,000 shares of the Company held by Sheng Rong.
FF003G
THE STOCK EXCHANGE OF HONG KONG LIMITED
(A wholly-owned subsidiary of Hong Kong Exchanges and Clearing Limited)
Name(s) of company(ies) listed on GEM or the Main Board of the Stock Exchange within the same group as the Company:
N/A
Financial year end date: 30 April
Registered address: P.O. Box 309
Ugland House Grand Cayman Cayman Islands
KY1-1104
Head office and principal place of business: 10th Floor, Dah Sing Financial Centre
108 Gloucester Road
Wanchai
Hong Kong
Web-site address (if applicable): www.bmregeneration.com
Share registrar: Principal Share Registrar:
Maples Fund Services (Cayman) Limited
P.O. Box 1093
Boundary Hall Cricket Square Grand Cayman Cayman Islands KY1-1102
Hong Kong Branch Share Registrar:
Union Registrars Limited
A18/F., Asia Orient Tower Town Place, 33 Lockhart Road Wanchai
Hong Kong
Auditors: BDO Limited
B. Business activities(Please insert here a brief description of the business activities undertaken by the Company and its subsidiaries.)
The Group is principally engaged in research and development of bio-medical and healthcare products, and medical techniques; the provision of the production and sales of tissue engineering products and its related by- products; as well as sales and distribution of medical products and equipment.
FF003G
THE STOCK EXCHANGE OF HONG KONG LIMITED
(A wholly-owned subsidiary of Hong Kong Exchanges and Clearing Limited)
C. Ordinary shares
Number of ordinary shares in issue: 11,912,880,000
Par value of ordinary shares in issue: HK$0.01 per share
Board lot size (in number of shares): 5,000 shares per board lot
Name of other stock exchange(s) on
N/A
which ordinary shares are also listed:
Stock code: N/A
Board lot size: N/A
Expiry date: N/A
Exercise price: N/A
Conversion ratio:
(Not applicable if the warrant is denominated in dollar value of conversion right)
N/A
No. of warrants outstanding: N/A
No. of shares falling to be issued upon the exercise of outstanding warrants:
N/A
Details of any other securities in issue.
(i.e. other than the ordinary shares described in C above and warrants described in D above but including options granted to executives and/or employees).
(Please include details of stock code if listed on GEM or the Main Board or the name of any other stock exchange(s) on which such securities are listed).
If there are any debt securities in issue that are guaranteed, please indicate name of guarantor. N/A
The directors of the Company (the "Directors") as at the date hereof hereby collectively and individually accept full responsibility for the accuracy of the information contained in this information sheet ("the Information") and confirm, having made all reasonable inquiries, that to the best of their knowledge and belief the Information is accurate and complete in all material respects and not misleading or deceptive and that there are no other matters the omission of which would make any Information inaccurate or misleading.
The Directors also collectively and individually accept full responsibility for submitting a revised information sheet, as soon as reasonably practicable after any particulars on the form previously published cease to be accurate.
FF003G
THE STOCK EXCHANGE OF HONG KONG LIMITED
(A wholly-owned subsidiary of Hong Kong Exchanges and Clearing Limited)
The Directors acknowledge that the Stock Exchange has no responsibility whatsoever with regard to the Information and undertake to indemnify the Exchange against all liability incurred and all losses suffered by the Exchange in connection with or relating to the Information.
Signed:
Dai Yumin Wang Yurong
Wong Sai Hung Deng Shaoping
Cao Fushun Yang Zhengguo
Ma Long Wang Jianjun
Lui Tin Nang Chan Wing Hang
Pang Chung Fai Benny Chan Bing Woon
NOTES
(1) This information sheet must be signed by or pursuant to a power of attorney for and on behalf of each of the Directors of the Company.
(2) Pursuant to rule 17.52 of the GEM Listing Rules, the Company must submit to the Exchange (in the electronic format specified by the Exchange from time to time) for publication on the GEM website a revised information sheet, together with a hard copy duly signed by or on behalf of each of the Directors, as soon as reasonably practicable after any particulars on the form previously published cease to be accurate.
(3) Please send a copy of this form by facsimile transaction to Hong Kong Securities Clearing Company Limited (on 2815-9353) or such other number as may be prescribed from time to time) at the same time as the original is submitted to the Exchange.
|
distributed by
|
